Doximity Inc. [NYSE: DOCS] loss -3.32% or -1.96 points to close at $57.10 with a heavy trading volume of 4650527 shares. The company report on November 17, 2021 that Doximity to Participate in Upcoming Investor Events.
Doximity Executives To Take Part in Piper Sandler Healthcare Conference, Raymond James Technology Conference.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, announced that it will participate in virtual fireside chats at the following upcoming investor events.
If we look at the average trading volume of 2.65M shares, DOCS reached to a volume of 4650527 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Doximity Inc. [DOCS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DOCS shares is $74.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DOCS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Robert W. Baird have made an estimate for Doximity Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on November 17, 2021. While these analysts kept the previous recommendation, Piper Sandler raised their target price from $68 to $81. The new note on the price target was released on November 10, 2021, representing the official price target for Doximity Inc. stock. Previously, the target price had yet another raise from $62 to $90, while Needham kept a Buy rating on DOCS stock. On November 10, 2021, analysts increased their price target for DOCS shares from 71 to 72.
The Average True Range (ATR) for Doximity Inc. is set at 4.97, with the Price to Sales ratio for DOCS stock in the period of the last 12 months amounting to 41.27. The Price to Book ratio for the last quarter was 13.76, with the Price to Cash per share for the same quarter was set at 3.70.
Trading performance analysis for DOCS stock
Doximity Inc. [DOCS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.78.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DOCS stock in for the last two-week period is set at 33.86, with the RSI for the last a single of trading hit 28.11, and the three-weeks RSI is set at 37.77 for Doximity Inc. [DOCS]. The present Moving Average for the last 50 days of trading for this stock 75.15, while it was recorded at 62.47 for the last single week of trading.
Doximity Inc. [DOCS]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Doximity Inc. [DOCS] shares currently have an operating margin of +26.00 and a Gross Margin at +84.92. Doximity Inc.’s Net Margin is presently recorded at +10.42.
Return on Total Capital for DOCS is now 45.92, given the latest momentum, and Return on Invested Capital for the company is 18.63. Return on Equity for this stock inclined to 18.68, with Return on Assets sitting at 10.92. When it comes to the capital structure of this company, Doximity Inc. [DOCS] has a Total Debt to Total Equity ratio set at 0.85. Additionally, DOCS Total Debt to Total Capital is recorded at 0.84, with Total Debt to Total Assets ending up at 0.49. Long-Term Debt to Equity for the company is recorded at 0.43, with the Long-Term Debt to Total Capital now at 0.19.
Receivables Turnover for the company is 5.41 with a Total Asset Turnover recorded at a value of 1.05.Doximity Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.70 and a Current Ratio set at 8.70.
An analysis of insider ownership at Doximity Inc. [DOCS]
There are presently around $1,712 million, or 48.60% of DOCS stock, in the hands of institutional investors. The top three institutional holders of DOCS stocks are: PRICE T ROWE ASSOCIATES INC /MD/ with ownership of 5,156,496, which is approximately 21.483% of the company’s market cap and around 8.10% of the total institutional ownership; VANGUARD GROUP INC, holding 4,193,557 shares of the stock with an approximate value of $239.45 million in DOCS stocks shares; and WHALE ROCK CAPITAL MANAGEMENT LLC, currently with $224.55 million in DOCS stock with ownership of nearly 77.924% of the company’s market capitalization.
Positions in Doximity Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 110 institutional holders increased their position in Doximity Inc. [NYSE:DOCS] by around 12,590,341 shares. Additionally, 71 investors decreased positions by around 6,856,076 shares, while 8 investors held positions by with 10,535,445 shares. The mentioned changes placed institutional holdings at 29,981,862 shares, according to the latest SEC report filing. DOCS stock had 85 new institutional investments in for a total of 4,147,395 shares, while 52 institutional investors sold positions of 3,369,067 shares during the same period.